Marchés français ouverture 2 h 53 min

Medtronic plc (MDT)

NYSE - NYSE Prix différé. Devise en USD
Ajouter à la liste dynamique
82,70+1,95 (+2,41 %)
À la clôture : 04:00PM EDT
83,18 +0,48 (+0,58 %)
Échanges après Bourse : 07:08PM EDT

Medtronic plc

20 On Hatch
Lower Hatch Street
Dublin 2
Ireland
353 1 438 1700
https://www.medtronic.com

Secteur(s)Healthcare
Secteur d’activitéMedical Devices
Employés à temps plein95 000

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Mr. Geoffrey Straub MarthaChairman & CEO4,35M1,63M1970
Ms. Karen L. ParkhillEVP, CFO, IT & Enterprise Excellence2,41MS.O.1965
Mr. Ivan K. FongExec. VP, Gen. Counsel & Sec.985,57kS.O.1961
Mr. Robert J. W. ten HoedtExec. VP and Pres, Europe, Middle East, Africa Region & Asia Pacific2,02MS.O.1960
Mr. Robert John WhiteExec. VP & Pres of Medical Surgical Portfolio2MS.O.1963
Mr. Mark PloofSr. VP of Global Operations and Bus. ServicesS.O.S.O.S.O.
Ms. Jennifer M. KirkPrincipal Accounting Officer, Global Controller & Chief Accounting OfficerS.O.S.O.1975
Dr. Laura Mauri M.D., M.Sc.Sr. VP and Chief Scientific, Medical & Regulatory OfficerS.O.S.O.S.O.
Mr. Sean LennonChief Information OfficerS.O.S.O.S.O.
Mr. Ryan WeispfenningVP of Investor RelationsS.O.S.O.S.O.
Les montants ont été établis en date du 31 décembre 2022 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Medtronic plc en date du 1 octobre 2022 est 6. Les scores principaux sont Audit : 8; Société : 7; Droits des actionnaires : 6; Compensation : 5.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.